139 related articles for article (PubMed ID: 18061955)
21. Evaluation of a manual CD4+ count kit for determination of absolute CD4+ T-lymphocyte counts.
Mitchai M; Susaengrat W; Krissadarak K; Mitchai J; Leeratanapetch N
J Med Assoc Thai; 2008 Oct; 91(10):1495-8. PubMed ID: 18972890
[TBL] [Abstract][Full Text] [Related]
22. Performance of the Panleucogating protocol for CD4+ T cell enumeration in an HIV dedicated laboratory facility in Barbados.
Sippy-Chatrani N; Marshall S; Branch S; Carmichael-Simmons K; Landis RC; Abayomi A
Cytometry B Clin Cytom; 2008; 74 Suppl 1():S65-8. PubMed ID: 18228556
[TBL] [Abstract][Full Text] [Related]
23. Simplified cytometry for routine monitoring of infectious diseases.
Janossy G; Shapiro H
Cytometry B Clin Cytom; 2008; 74 Suppl 1():S6-10. PubMed ID: 18228555
[TBL] [Abstract][Full Text] [Related]
24. A new affordable flow cytometry based method to measure HIV-1 viral load.
Greve B; Weidner J; Cassens U; Odaibo G; Olaleye D; Sibrowski W; Reichelt D; Nasdala I; Göhde W
Cytometry A; 2009 Mar; 75(3):199-206. PubMed ID: 19034933
[TBL] [Abstract][Full Text] [Related]
25. [Decentralization of the immunological monitoring of people living with HIV/AIDS in a limiting setting with a low HIV seroprevalence: the experience of Senegal].
Diaw PA; Sylla Niang M; Touré Kane C; Dieye TD; Diop Ndiaye H; Wade AS; Dieye A; Mboup S
Ann Biol Clin (Paris); 2008; 66(4):409-16. PubMed ID: 18725342
[TBL] [Abstract][Full Text] [Related]
26. CD4 T cell measurements in the management of antiretroviral therapy--A review with an emphasis on pediatric HIV-infected patients.
O'Gorman MR; Zijenah LS
Cytometry B Clin Cytom; 2008; 74 Suppl 1():S19-26. PubMed ID: 18228562
[TBL] [Abstract][Full Text] [Related]
27. Effective evaluation of novel low-cost CD4 monitoring assays.
Cecelia AJ; Balakrishnan P; Mohanakrishnan ; Venkatakrishnan B; Solomon S; Kumarasamy N
J Immunol Methods; 2006 Oct; 316(1-2):158-62. PubMed ID: 16997318
[TBL] [Abstract][Full Text] [Related]
28. Impact of the international program for Quality Assessment and Standardization for Immunological Measures Relevant to HIV/AIDS: QASI.
Mandy F; Bergeron M; Houle G; Bradley J; Fahey J
Cytometry; 2002 Apr; 50(2):111-6. PubMed ID: 12116353
[TBL] [Abstract][Full Text] [Related]
29. The evolution of CD4+ T cell cytometry in perspective: challenges for resource poor settings.
Arewa OP
Afr J Med Med Sci; 2010 Mar; 39(1):5-12. PubMed ID: 20632666
[TBL] [Abstract][Full Text] [Related]
30. Magnetic bead based immunoassay for enumeration of CD4+ T lymphocytes on a microfluidic device.
Gao D; Li HF; Guo GS; Lin JM
Talanta; 2010 Jul; 82(2):528-33. PubMed ID: 20602931
[TBL] [Abstract][Full Text] [Related]
31. Difficulties in precise quantitation of CD4+ T lymphocytes for clinical trials: a review.
Fei DT; Paxton H; Chen AB
Biologicals; 1993 Sep; 21(3):221-31. PubMed ID: 7906948
[TBL] [Abstract][Full Text] [Related]
32. Immunologic features of HIV-1-infected women on HAART at delivery.
Ono E; Dos Santos AM; Machado DM; Succi RC; Amed AM; Salomão R; Kallás EG; de Moraes-Pinto MI
Cytometry B Clin Cytom; 2008 Jul; 74(4):236-43. PubMed ID: 18393385
[TBL] [Abstract][Full Text] [Related]
33. Evaluation of stabilized blood cell products as candidate preparations for quality assessment programs for CD4 T-cell counting.
Bergeron M; Shafaie A; Ding T; Phaneuf S; Soucy N; Mandy F; Bradley J; Fahey J
Cytometry; 2002 Apr; 50(2):86-91. PubMed ID: 12116350
[TBL] [Abstract][Full Text] [Related]
34. Flow cytometric CD4 enumeration of four different HIV-infected blood samples at the cost of one monoclonal antibody reagent.
Noulsri E; Lerdwana S; Sukapirom K; Thepthai C; Onlamoon N; Tassaneetrithep B; Pattanapanyasat K
Asian Pac J Allergy Immunol; 2011 Jun; 29(2):190-9. PubMed ID: 21980835
[TBL] [Abstract][Full Text] [Related]
35. Dried blood spot technology for CD4+ T-cell counting.
Shapiro HM; Mandy FF; Rinke de Wit TF; Sandstrom P
Lancet; 2004 Jan; 363(9403):164; author reply 164-5. PubMed ID: 14726173
[No Abstract] [Full Text] [Related]
36. CD4 validation for the World Health Organization classification and clinical staging of HIV/AIDS in a developing country.
Edathodu J; Ali B; Alrajhi AA
Int J Infect Dis; 2009 Mar; 13(2):243-6. PubMed ID: 18945632
[TBL] [Abstract][Full Text] [Related]
37. Cirrhosis is associated with low CD4+ T cell counts: implications for HIV-infected patients with liver disease.
Gandhi RT
Clin Infect Dis; 2007 Feb; 44(3):438-40. PubMed ID: 17205455
[No Abstract] [Full Text] [Related]
38. Increased NKG2A found in cytotoxic natural killer subset in HIV-1 patients with advanced clinical status.
Zhang R; Xu J; Hong K; Yuan L; Peng H; Tang H; Ma P; Zhang Y; Xing H; Ruan Y; Shao Y
AIDS; 2007 Dec; 21 Suppl 8():S9-17. PubMed ID: 18172398
[TBL] [Abstract][Full Text] [Related]
39. When to initiate highly active antiretroviral therapy in low-resource settings: the Moroccan experience.
Loubiere S; el Filal KM; Sodqi M; Loundou A; Luchini S; Cleary S; Moatti JP; Himmich H
Antivir Ther; 2008; 13(2):241-51. PubMed ID: 18505175
[TBL] [Abstract][Full Text] [Related]
40. Beckman Coulter and CD4+ T cells.
Rabellino EM; Forman MA; Howes GC; Mills RA; Quintana JA; Roth PA; Wilkinson JG
Cytometry; 2002 Apr; 50(2):127-8. PubMed ID: 12116355
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
